Studies on durability of sustainable biobased composites: a review

Global concerns over environmental issues have led to a tremendous growth in sustainable materials emerging from biobased plastics and their composites (biocomposites). This class of materials can be an alternative to traditional composite materials to reduce the carbon footprint and strain on the environment. Many studies and reviews have been focused on enhancing the mechanical performance of biocomposites with the aim for them to compete with traditional composites and expand their applications. However, the current scientific knowledge relating to the long-term durability performance of biocomposites is very limited in open access literature. Studies of the effects of different aging mechanisms when subjected to different service conditions and environments on the biocomposites'' behaviours are needed. This review provides a focused discussion on the overview of the long-term durability performance and degradation behaviour under various aging environments (thermo-oxidative aging, accelerated weathering (ultraviolet aging), hydrolytic degradation, fatigue and creep, etc.) of the commercially important biobased-composites for the first time. Future perspectives and methods to improve the durability performance of biocomposites are also discussed in this review.

This review provides a comprehensive discussion on the long-term durability performance and degradation behaviour of the increasingly popular sustainable biobased composites under various aging environments.     

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

European Journal of Nuclear Medicine and Molecular Imaging - One-third of patients with RAS wild-type mCRC do not benefit from anti-EGFR monoclonal antibodies. This might be a result of variable...     

The influence of the ambient temperature on blood pressure and how it will affect the epidemiology of hypertension in Asia

Epidemiologic studies have consistently demonstrated an increased risk of cardiovascular disease during colder temperatures. Hemodynamic changes associated with cold temperature and an increase in thrombogenicity may both account for the increase in cardiovascular risk and mortality. Studies using both in‐office and out‐of‐office BP measurements have consistently shown an elevation in BP during the colder seasons. The large difference in BP between cold and warm months may increase the incidence of hypertension and reduce the hypertension control rate, potentially resulting in increased cardiovascular risk, especially among those at risk of cardiovascular disease. The current trends in global warming and climate change may have a profound impact on the epidemiology of hypertension and cardiovascular disease, as changes in the climate may significantly affect both BP variability and cardiovascular disease, especially in those with high cardiovascular risk and the elderly. Furthermore, climate change could have a significant influence on hypertension in Asia, considering the unique characteristics of hypertensive patients in Asia. As an increase in ambient temperature decreases the mean daytime average and morning surge in BP, but increases the nocturnal BP, it is difficult to predict how environmental changes will affect the epidemiology and prognosis of hypertension in the Asian‐Pacific region. However, these seasonal variations in BP could be minimized by adjusting the housing conditions and using anticipation medicine. In this review, we discuss the impact of seasonal variation in the ambient temperature on hypertension and cardiovascular disease and discuss how this may impact the epidemiology of hypertension and cardiovascular disease.     

Survival analysis of cholangiocarcinoma: a 10-year experience in Malaysia

AIM: To investigate the clinical features and survival of patients treated for cholangiocarcinoma in our institution and to analyze the factors affecting their survival.METHODS: This retrospective cohort study assessed patients diagnosed with cholangiocarcinoma between January 1997 and December 2007 at the University Malaya Medical Centre in Malaysia. The clinical data and associated outcomes were collected using a structured proforma.RESULTS: Of the 69 patients diagnosed with cholangiocarcinoma, 38 (55%) were male; mean patient age was 61 years. Twelve patients (17%) had intrahepatic, 38 (55%) had perihilar and 19 (28%) had distal tumors. Only 12 patients underwent curative surgery, including seven R0 resections. Only one patient died within 30 d after surgery. The overall median survival was 4 mo, whereas the median survival of R0 resected patients was 16 mo. The overall 1-, 2- and 3-year cumulative survival rates were 67%, 17% and 17%, respectively. Survival rates were significantly associated with curative resection (P = 0.002), intrahepatic tumor (P = 0.003), negative margin status (P = 0.013), early tumor stage (P = 0.016), higher tumor differentiation (P = 0.032) and absence of jaundice (P = 0.038). Multivariate analysis showed that tumor location was a significant independent predictor of patient survival.CONCLUSION: Curative, margin-negative resection of early stage, well-differentiated intrahepatic tumors is associated with improved patient survival.